NEKO PHARMA
ActiveNEKO PHARMA has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €414k and a net result of €30k. Equity is growing by ~8.2% per year across the filed fiscal years. Its solvency ranks better than 52% of 6965 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability36▼-14
Solvency64▲+1
Growth78=
Stability100
Bankruptcy probability, 12 months
0.5%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €20k at 30 days acceptable
Liquidity short (current ratio 0.01 against 0.04 in 2024), and 43% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
57%
Return on assets
4.1%
Age of the figures
8 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-08-2026, 26 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 9 filingsDeviation from the deadline
2025
26 d late
2024
27 d late
2023
30 d late
2022
58 d late
2021
29 d late
2020
31 d late
2019
61 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
14-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€414k▲ 7.7%
2024 · €384k
2018: €197k
2019: €260k
2020: €294k
2021: €301k
2022: €323k
2023: €346k
2024: €384k
2018 → 2025
Total assets
€726k▼ 0.7%
2024 · €731k
2018: €742k
2019: €767k
2020: €769k
2021: €742k
2022: €732k
2023: €727k
2024: €731k
2018 → 2025
Net result
€30k▼ 22.2%
2024 · €38k
2018: €16k
2019: €62k
2020: €35k
2021: €7k
2022: €22k
2023: €23k
2024: €38k
2018 → 2025
Working capital
€-141k▼ 3.4%
2024 · €-136k
2018: €-124k
2019: €-94k
2020: €-92k
2021: €-118k
2022: €-130k
2023: €-141k
2024: €-136k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€301k-€323k▲ 7.3%€346k▲ 7.0%€384k▲ 11.0%€414k▲ 7.7%
Operating result€-5k-€-4k▲ 13.0%€-4k▼ 8.5%€-3k▲ 20.7%€-4k▼ 23.7%
Net result€7k-€22k▲ 210%€23k▲ 3.0%€38k▲ 68.3%€30k▼ 22.2%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €4k in 2025 against €3k in 2024; the loss grows.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €726k
Fixed assets
€725k=
Current assets
€792▼ 86.0%
Equity and liabilities €726k
Equity
€414k▲ 7.7%
Debt
€312k▼ 10.0%
The debt ratio falls from 47.4% to 43.0%: equity grows while debt is paid down.
Key figures and ratios
Solvency
57.0%▲
2024 · 52.6%
Current ratio
0.01▼
2024 · 0.04
Quick ratio
0.01▼
2024 · 0.04
Debt / equity
0.75▼
2024 · 0.90
ROE
7.2%▼
2024 · 9.9%
ROA
4.1%▼
2024 · 5.2%
Debt
€312k▼
2024 · €347k
Debt ≤ 1 year
€142k▼
2024 · €142k
Debt > 1 year
€170k▼
2024 · €205k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€731k€726k▼
Fixed assets21/28€725k€725k=
Financial fixed assets28€725k€725k=
Current assets29/58€6k€792▼
Amounts receivable within one year40/41€1k€252▼
Other amounts receivable41€1k€252▼
Cash at bank and in hand54/58€4k€540▼
Equity and liabilities
Total equity and liabilities10/49€731k€726k▼
Equity10/15€384k€414k▲
Contributions10/11€19k€19k=
Reserves13€365k€395k▲
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Distributable reserves133€364k€393k▲
Amounts payable17/49€347k€312k▼
Amounts payable after more than one year17€205k€170k▼
Financial debts170/4€205k€170k▼
Amounts payable within one year42/48€142k€142k▼
Current portion of amounts payable after more than one year42€34k€34k▲
Trade debts44€1k€600▼
Suppliers440/4€1k€600▼
Other amounts payable47/48€107k€107k=
Income statement
Code20242025
Other operating charges640/8-€66
Gross operating margin9900€-3k€-4k▼
Operating profit (loss)9901€-3k€-4k▼
Financial income75/76B€44k€36k▼
Recurring financial income75€44k€36k▼
Financial charges65/66B€2k€2k▼
Recurring financial charges65€2k€2k▼
Profit (loss) for the period before taxes9903€38k€30k▼
Profit (loss) for the period9904€38k€30k▼
Profit (loss) for the period to be appropriated9905€38k€30k▼
Appropriation of the result
Profit (loss) to be appropriated9906€38k€30k▼
Transfer to equity691/2€38k€30k▼
To other reserves6921€38k€30k▼
The notes to these accounts (3 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
26-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 26 days late
2025
27-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 27 days late
2024
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
27-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 58 days late
2022
29-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 29 days late
2021
31-12
Financial
Weakest financial yearnet €7k ▼79.5%
Net result drops to €7k, the lowest in the series; recovery starts the following year.
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
30-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 61 days late
2019
31-12
Financial
Highest result since 2018net €62k ▲293%
Net result €62k, the highest in the series.
31-12
Financial
Equity above €200kEq €260k ▲31.7%
2 profitable years in a row build equity to €260k.
27-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 27 days late
2018
29-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, La Louvière · 1 establishment unit since 2016
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue Saint-Nicolas(H-G) 357110 La LouvièreGround area
490 m²
Building footprint
78 m²
Volume, LiDAR
701 m³
Parcel 55020C0902/00E008, Wallonia · tallest building 10.8 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Neko Pharma
since 20162.256.633.536
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 55020C0902/00E008 | Wallonia | 490 m² | 1 · 78 m² | 10.8 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
SILVERGEST
BE 0718.603.120
Sint-Jans-Molenbeek · Eq €414k
FACE2FACE
BE 0830.050.477
Oostende · Eq €414k
FEHRENBACH CONSULT
BE 0846.696.667
La Bruyère · Eq €413k
STEIN VANHOVE
BE 0840.544.491
Tongeren-Borgloon · Eq €414k
SUADA
BE 0467.205.646
Pajottegem · Eq €412k
Of 13,391 companies in sector 73300 we hold annual accounts for 6,881. 4,418 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company (pre-2019)
Founded30-08-2016
Fiscal year end31-12
Activities, NACEBEL
70210Activities of head offices; management consultancy activities
73300Public relations and communication consultancy
70200Business and other management consultancy
70220Business consulting
Sources
Crossroads Bank for EnterprisesNational Bank · 9 filingsAddress and cadastre registers
Data from official sources, last processed on 14-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryPhone:0472/735973